Immunome Inc.·4

Mar 26, 4:03 PM ET

SIEGALL CLAY B 4

4 · Immunome Inc. · Filed Mar 26, 2025

Insider Transaction Report

Form 4
Period: 2025-03-26
SIEGALL CLAY B
DirectorPresident and CEO
Transactions
  • Purchase

    Common Stock

    2025-03-26$7.29/sh+137,100$999,459806,736 total
Footnotes (1)
  • [F1]The weighted average purchase price for the transaction report was $7.29, and the range of prices were between $7.16 and $7.40, inclusive. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided.

Documents

1 file
  • 4
    form4-03262025_080357.xmlPrimary